Medpace Holdings, Inc.
MEDP
$297.31
$3.731.27%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.16B | 2.11B | 2.07B | 2.03B | 1.96B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.16B | 2.11B | 2.07B | 2.03B | 1.96B |
| Cost of Revenue | 688.42M | 682.10M | 678.86M | 671.69M | 658.67M |
| Gross Profit | 1.47B | 1.43B | 1.39B | 1.36B | 1.30B |
| SG&A Expenses | 194.00M | 180.18M | 177.27M | 169.46M | 167.41M |
| Depreciation & Amortization | 29.19M | 29.25M | 28.72M | 28.08M | 27.36M |
| Other Operating Expenses | 788.65M | 770.65M | 777.21M | 779.38M | 754.68M |
| Total Operating Expenses | 1.70B | 1.66B | 1.66B | 1.65B | 1.61B |
| Operating Income | 456.32M | 446.87M | 408.81M | 381.45M | 354.69M |
| Income Before Tax | 481.31M | 475.92M | 432.75M | 397.17M | 362.43M |
| Income Tax Expenses | 64.92M | 71.54M | 67.08M | 57.38M | 49.93M |
| Earnings from Continuing Operations | 416.39 | 404.39 | 365.67 | 339.79 | 312.51 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 416.39M | 404.39M | 365.67M | 339.79M | 312.51M |
| EBIT | 456.32M | 446.87M | 408.81M | 381.45M | 354.69M |
| EBITDA | 485.51M | 476.12M | 437.53M | 409.52M | 382.05M |
| EPS Basic | 13.51 | 13.06 | 11.83 | 11.02 | 10.17 |
| Normalized Basic EPS | 9.75 | 9.61 | 8.75 | 8.06 | 7.38 |
| EPS Diluted | 13.10 | 12.63 | 11.42 | 10.63 | 9.81 |
| Normalized Diluted EPS | 9.46 | 9.29 | 8.45 | 7.77 | 7.12 |
| Average Basic Shares Outstanding | 123.37M | 123.83M | 123.60M | 123.18M | 122.73M |
| Average Diluted Shares Outstanding | 127.24M | 128.05M | 128.00M | 127.67M | 127.16M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |